A detailed history of Black Rock Inc. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,762,157 shares of MCRB stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,762,157
Previous 6,825,399 74.18%
Holding current value
$1.62 Million
Previous $5.26 Million 75.87%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.56 - $1.19 $2.84 Million - $6.03 Million
-5,063,242 Reduced 74.18%
1,762,157 $1.27 Million
Q1 2024

May 10, 2024

SELL
$0.75 - $1.56 $385,541 - $801,925
-514,055 Reduced 7.0%
6,825,399 $5.26 Million
Q4 2023

Feb 13, 2024

SELL
$0.93 - $2.15 $541,700 - $1.25 Million
-582,474 Reduced 7.35%
7,339,454 $10.3 Million
Q3 2023

Nov 13, 2023

BUY
$2.33 - $5.07 $1.03 Million - $2.23 Million
440,701 Added 5.89%
7,921,928 $18.9 Million
Q2 2023

Aug 11, 2023

BUY
$4.67 - $6.55 $5.75 Million - $8.07 Million
1,232,141 Added 19.72%
7,481,227 $35.8 Million
Q1 2023

May 12, 2023

SELL
$4.95 - $6.09 $1.04 Million - $1.28 Million
-209,888 Reduced 3.25%
6,249,086 $35.4 Million
Q4 2022

Feb 13, 2023

BUY
$5.09 - $9.05 $807,396 - $1.44 Million
158,624 Added 2.52%
6,458,974 $36.2 Million
Q3 2022

Nov 14, 2022

BUY
$3.5 - $7.2 $1.89 Million - $3.89 Million
539,617 Added 9.37%
6,300,350 $40.5 Million
Q2 2022

Aug 12, 2022

SELL
$2.7 - $7.62 $360,981 - $1.02 Million
-133,697 Reduced 2.27%
5,760,733 $19.8 Million
Q1 2022

May 12, 2022

BUY
$6.3 - $8.84 $199,955 - $280,572
31,739 Added 0.54%
5,894,430 $42 Million
Q4 2021

Feb 10, 2022

BUY
$6.02 - $11.43 $119,701 - $227,274
19,884 Added 0.34%
5,862,691 $48.8 Million
Q3 2021

Nov 09, 2021

SELL
$5.46 - $22.6 $3.16 Million - $13.1 Million
-578,178 Reduced 9.0%
5,842,807 $40.7 Million
Q2 2021

Aug 11, 2021

BUY
$18.46 - $24.36 $119 Million - $156 Million
6,420,985 New
6,420,985 $153 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $114M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.